Loading…
Encompass Health Corporation is projected to rise to $129.46 by 2027, a +18% move from its current price of $110.16. EHC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $108.49 | $110.22 | $111.97 | +0.05% |
| Jul 14 | $107.84 | $110.27 | $112.76 | +0.10% |
| Jul 15 | $107.35 | $110.33 | $113.38 | +0.15% |
| Jul 16 | $106.95 | $110.38 | $113.92 | +0.20% |
| Jul 17 | $106.61 | $110.44 | $114.40 | +0.25% |
| Jul 18 | $106.31 | $110.49 | $114.84 | +0.30% |
| Jul 19 | $106.03 | $110.55 | $115.26 | +0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $106.03 | $110.55 | $115.26 | +0.35% |
| Week 2 | $104.58 | $110.94 | $117.68 | +0.70% |
| Week 3 | $103.57 | $111.33 | $119.67 | +1.06% |
| Week 4 | $102.77 | $111.72 | $121.44 | +1.41% |
| Week 5 | $102.13 | $112.11 | $123.07 | +1.77% |
| Week 6 | $101.58 | $112.50 | $124.61 | +2.13% |
| Week 7 | $101.10 | $112.90 | $126.07 | +2.49% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Encompass Health Corporation operates inpatient rehabilitation hospitals in the United States and Puerto Rico. The company offers specialized rehabilitative treatment, using technology and therapy, on an inpatient basis for patients recovering from a major injury or illness and seeking to regain functional ability, independence, and quality of life; medical, nursing, therapy, and ancillary services; and rehabilitative care to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. It offers services through the Medicare program to the federal government, managed care plans and private insurers, state governments, and other patients.
The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was incorporated in 1984 and is based in Birmingham, Alabama.
Encompass Health Corporation trades as EHC in the Healthcare sector. The stock is currently priced at $106.46 with a market cap of $10.56B and a rank of 874. The current price and market position place it among mid-cap healthcare holdings focused on inpatient rehabilitation services across the United States and Puerto Rico.
A major floor 15.4% below — a decisive break under it would weaken the trend.
The nearest floor, 11.1% below — buyers have tended to step in here.
Price is pressing into resistance (0.8% away) — a breakout level to watch.
A major ceiling 8.5% above — clearing it would confirm fresh momentum.
Key EHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $109.83 | Buy | $109.24 | Buy |
| MA 10 | $106.03 | Buy | $107.05 | Buy |
| MA 20 | $102.99 | Buy | $104.99 | Buy |
| MA 50 | $104.02 | Buy | $103.95 | Buy |
| MA 100 | $103.79 | Buy | $104.48 | Buy |
| MA 200 | $108.05 | Buy | $106.09 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 64.89 | Neutral |
| Stoch RSI (14) | 88.77 | Sell |
| CCI (20) | 126.93 | Buy |
| Williams %R (14) | -6.97 | Info |
| MACD (12,26,9) | 1.27 | Buy |
| ROC (12) | 10.27 | Buy |
| Bollinger %B (20,2) | 0.91 | Neutral |
| Stochastic %K (14) | 93.03 | Sell |
| TRIX (15) | 0.06 | Buy |
| Awesome (5,34) | 6.60 | Buy |
| Ultimate (7,14,28) | 81.11 | Sell |
| Momentum (10) | 10.44 | Buy |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 112.65 | Sell |
| ADX (14) | 16.85 | Neutral |
| ATR (14) | 1.47 | Info |
The 30-day technical picture shows a bullish bias. The RSI14 is 60, and the near-term price action sits near the moving averages with the SMA50 at $103.21 and the SMA200 at $108.42. A key near-term resistance is at $106.46, with support at $97.89.
The 30-day range runs from $95.39 to $118.81, reflecting a contained but constructive trading window and about 30% annualized volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $93.83 | $110.16 | $147.60 | 0% | Neutral | |
| $106.03 | $129.46 | $165.26 | +18% | Neutral | |
| $113.75 | $141.50 | $185.51 | +28% | Bullish | |
| $121.44 | $153.39 | $205.39 | +39% | Bullish | |
| $133.59 | $171.01 | $233.11 | +55% | Bullish | |
| $156.44 | $202.71 | $280.68 | +84% | Bullish | |
| $173.64 | $227.54 | $319.55 | +107% | Bullish | |
| $194.60 | $257.70 | $366.58 | +134% | Bullish | |
| $204.94 | $274.09 | $394.57 | +149% | Bullish | |
| $200.53 | $270.74 | $394.07 | +146% | Bullish | |
| $307.89 | $433.55 | $661.32 | +294% | Bullish | |
| $549.79 | $830.30 | $1,357.61 | +654% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $93.83 | $110.16 | $130.49 | +0.00% |
| August 2026 | $94.82 | $110.99 | $132.72 | +0.75% |
| September 2026 | $98.04 | $115.31 | $138.97 | +3.89% |
| October 2026 | $101.04 | $119.32 | $144.75 | +3.48% |
| November 2026 | $100.76 | $119.40 | $145.65 | +0.07% |
| December 2026 | $101.26 | $120.39 | $147.60 | +0.82% |
Click any year to see its month-by-month EHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect EHC to range from $93.83 to $147.60 through 2026. The $110.16 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The EHC price prediction for 2027 points to an average of $129.46 (low $106.03, high $165.26) — a potential gain of +18% on today's $110.16. Price action looks broadly range-bound.
In 2028, EHC is projected to trade between $113.75 and $185.51, averaging $141.50 — a potential gain of +28% from today's $110.16. That is up +9% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Encompass Health Corporation's 2029 outlook centres on $153.39, within a $121.44 to $205.39 range. That is up +8% on the projected 2028 average. That marks a +39% change versus current levels. Momentum favours further upside here.
By 2030, EHC could reach as high as $233.11, with a base case around $171.01 and support toward $133.59 — roughly +55% from $110.16. Buyers look set to stay in control over this stretch.
Expect EHC to range from $156.44 to $280.68 through 2031. The $202.71 average target implies a +84% move from current prices. That is up +19% on the projected 2030 average. Momentum favours further upside here.
The EHC price prediction for 2032 points to an average of $227.54 (low $173.64, high $319.55) — a potential gain of +107% on today's $110.16. Buyers look set to stay in control over this stretch.
In 2033, EHC is projected to trade between $194.60 and $366.58, averaging $257.70 — a potential gain of +134% from today's $110.16. That is up +13% on the projected 2032 average. Momentum favours further upside here.
Encompass Health Corporation's 2034 outlook centres on $274.09, within a $204.94 to $394.57 range. That is up +6% on the projected 2033 average. That marks a +149% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, EHC could reach as high as $394.07, with a base case around $270.74 and support toward $200.53 — roughly +146% from $110.16. Momentum favours further upside here.
Expect EHC to range from $307.89 to $661.32 through 2040. The $433.55 average target implies a +294% move from current prices. That is up +60% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The EHC price prediction for 2050 points to an average of $830.30 (low $549.79, high $1,357.61) — a potential gain of +654% on today's $110.16. Momentum favours further upside here.
Investing $1,000 in EHC today (≈ 9.077705 EHC) could be worth
$7,537.23
+$6,537.23 (+654%) by 2050 · US Dollar
Based on the average projected EHC price of $830.3 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EHCwould be worth at today's price.
$1,000 invested in EHC on Jul 10, 2025 (≈ 8.511363 EHC) would be worth
$937.61
-$62.39 (-6.2%) today · 0.94× · US Dollar
Based on a EHC entry price of $117.49 vs. today's $110.16.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $106.46 | $1,034.75 | +3.5% |
| 1 month ago | $103.35 | $1,065.89 | +6.6% |
| 3 months ago | $107.25 | $1,027.13 | +2.7% |
| 6 months ago | $102.76 | $1,072.01 | +7.2% |
| 1 year ago | $117.49 | $937.61 | -6.2% |
| All time (5.0y) ago | $63.8 | $1,726.57 | +72.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EHC forecast.
Our base-case forecast reaches $220.00 around 2032.
Implied market cap at $220.00: $21.82B
The multi-year forecast points to a bullish trajectory for Encompass Health over the medium and long term. The year-by-year averages show a rising path from 2026 through 2050, with the 2026 average at $106.46 and the 2027 average at $124.52, rising to $162.29 by 2030, $402.49 by 2040, and $771.97 by 2050. The forecasted maximums climb to $221.30 in 2030, $614.07 in 2040, and $1,262.41 in 2050, while ROIs rise to 52.4% by 2030, 278.1% by 2040, and 625.1% by 2050.
Sentiment shifts from Neutral in 2026 to Bullish in the later years, highlighting upside potential but acknowledging these are estimates, not guarantees.
Tap a question to reveal the answer.
2030 avg $162.29; min $126.73; max $221.30; ROI 52.4%; sentiment BULLISH.
The forecast shows Neutral in 2026 and Neutral in 2027, then Bullish from 2028 onward, with 2028 avg $134.67, 2029 avg $147.82, 2030 avg $162.29, 2040 avg $402.49, and 2050 avg $771.97. ROIs rise to 52.4% by 2030 and 625.1% by 2050. These are estimates, not guarantees.
Yes—the 2050 max forecast is $1,262.41, indicating potential to exceed $1,000, though this is not guaranteed.
Current price is $106.46. The 30-day range is $95.39 to $118.81. RSI14 is 60, SMA50 is $103.21, SMA200 is $108.42. Support is $97.89 and resistance is $106.46. The near-term sentiment is bullish.
The long-term view shows 2030 avg $162.29, 2040 avg $402.49, and 2050 avg $771.97, with max values $221.30, $614.07, and $1,262.41 respectively and ROIs of 52.4%, 278.1%, and 625.1%. The sentiment is bullish across the horizon.
Encompass Health Corporation Community Discussion
0Share your Encompass Health Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.